Part of our mission is clinical research to discover the full potential of proton therapy in the fight against cancer. In our first decade, our research has made significant contributions to the medical community’s understanding of proton therapy patient outcomes. With more than 150 published journal articles, we have reported long-term prostate cancer outcomes, pediatric brain tumor outcomes, Hodgkin lymphoma outcomes and more than a dozen other disease sites. Last month, Medical Director Nancy P. Mendenhall, MD, was named Clinical Science Researcher of the Year by the University of Florida. We congratulate her on receiving this recognition and are proud to support her quest to uncover more about what protons can do to heal.
Stuart L. Klein